\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ \\-\\ unremarkable\ \(0\)\
\-\ labs\\:\\ \\ cmp\\,\\ amylase\\,\\ lipase\\ pending\ \(0\)\
\-\ no\\ specific\\ treatment\\ at\\ this\\ time\\.\\ \\ follow\\-up\\ with\\ liver\\ function\\ tests\\ to\\ determine\\ if\\ stable\\ or\\ continuing\\ to\\ rise\\.\ \(0\)\
\-\ selected\\ images\\ \\â\\€\\“\\ ct\\ \\(contrast\\,\\ arterial\\ phase\\)\\ of\\ abdomen\\/pelvis\ \(0\)\
\-\ 1\\.\\ \\ large\\,\\ diffusely\\ infiltrated\\ fatty\\ liver\\ with\\ accessory\\ left\\ lobe\\.\\ \\ compare\\ to\\ density\\ of\\ spleen\\.\\ \\ multiple\\ areas\\ of\\ focal\\ sparing\\ in\\ left\\ lobe\\ that\\ appears\\ nodular\\.\\ \\ \ \(0\)\
\-\ 2\\.\\ \\ area\\ of\\ focal\\ sparing\\ near\\ portal\\ vein\\.\ \(0\)\
\-\ 3\\.\\ \\ area\\ focal\\ sparing\\ in\\ left\\ lobe\\.\\ \\ renal\\ cyst\\ and\\ renal\\ calculi\\.\ \(0\)\
\-\ hepatic\\ fatty\\ infiltration\\ with\\ focal\\ sparing\ \(0\)\
\-\ hepatomegaly\ \(15\)\
\-\ 1\\.\\	metabolic\\/diffuse\\ infiltration\ \(0\)\
\-\ \\â\\€\\¢\\	fatty\\ infiltration\\ \\â\\€\\“\\ etoh\\,\\ drugs\\,\\ toxins\\,\\ guacher\\â\\€\\™s\ \(0\)\
\-\ \\â\\€\\¢\\	carbohydrate\\ \\â\\€\\“\\ diabetes\\,\\ glycogen\\ storage\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\	iron\\ \\â\\€\\“\\ hemochromatosis\ \(0\)\
\-\ \\â\\€\\¢\\	amyloid\\ \\-\\ amyloidosis\ \(0\)\
\-\ 2\\.\\	tumor\ \(0\)\
\-\ 3\\.\\	cysts\ \(0\)\
\-\ 4\\.\\	inflammation\\/infection\ \(0\)\
\-\ 5\\.\\	vascular\\ congestion\ \(0\)\
\-\ nodular\\ appearance\ \(5\)\
\-\ 1\\.\\	focal\\ fat\\ infiltration\\/sparing\ \(1\)\
\-\ 2\\.\\	hepatocellular\\ carcinoma\ \(1\)\
\-\ 3\\.\\	metastases\ \(1\)\
\-\ this\\ is\\ 51\\ year\\ old\\ woman\\ \\ with\\ known\\ history\\ of\\ nephrolithiasis\\ and\\ left\\ renal\\ cyst\\.\\ \\ she\\ was\\ being\\ followed\\ for\\ stones\\ and\\ had\\ long\\ history\\ of\\ abdominal\\/pelvic\\ ct\\â\\€\\™s\\ and\\ kub\\ films\\.\ \(0\)\
\-\ previous\\ non\\-contrast\\ abdominal\\ ct\\ dating\\ back\\ approx\\ 6\\ months\\ showed\\ evidence\\ for\\ diffuse\\ fatty\\ infiltration\\ and\\ hepatomegaly\\.\\ \\ additionally\\,\\ a\\ non\\-contrast\\ ct\\ performed\\ 1\\ month\\ ago\\ showed\\ increased\\ thickness\\ of\\ the\\ pancreatic\\ head\\.\\ \\ a\\ pre\\-\\ and\\ post\\-contrast\\ ct\\ were\\ obtained\\ to\\ evaluate\\ for\\ change\\.\ \(0\)\
\-\ this\\ is\\ a\\ presumptive\\ diagnosis\\ of\\ diffuse\\ fatty\\ liver\\ disease\\.\\ \\ the\\ causes\\ for\\ which\\ are\\ many\\,\\ for\\ instance\\,\\ alcoholism\\,\\ obesity\\,\\ malnutrition\\,\\ steroid\\ therapy\\,\\ and\\ diabetes\\ mellitus\\.\\ laboratory\\ testing\\ of\\ liver\\ function\\ tests\\ could\\ aid\\ in\\ further\\ diagnosis\\.\\ \\ ct\\ imaging\\ is\\ consistent\\ with\\ this\\ diagnosis\\ as\\ the\\ liver\\ appears\\ less\\ dense\\ than\\ the\\ spleen\\.\\ \\ given\\ that\\ the\\ liver\\ findings\\ were\\ discovered\\ incidentally\\ and\\ the\\ patient\\ has\\ been\\ asymptomatic\\ there\\ is\\ no\\ need\\ to\\ aggressively\\ pursue\\ this\\ with\\ further\\ imaging\\ or\\ biopsy\\.\\ \\ however\\,\\ from\\ a\\ medical\\ record\\ review\\,\\ the\\ patient\\ reported\\ that\\ her\\ primary\\ care\\ manager\\ requested\\ that\\ she\\ be\\ taken\\ off\\ acetaminophen\\ because\\ of\\ high\\ liver\\ function\\ tests\\.\\ \\ the\\ results\\ of\\ this\\ test\\ were\\ unavailable\\.\\ so\\ significant\\ delay\\ in\\ diagnosis\\ could\\ lead\\ to\\ long\\-term\\ liver\\ damage\\.\\ \\ furthermore\\,\\ most\\ cases\\ of\\ fatty\\ liver\\ disease\\ will\\ resolve\\ if\\ the\\ etiology\\ is\\ discovered\\ and\\ the\\ offending\\ agent\\ is\\ removed\\.\ \(0\)\
\-\ the\\ appearance\\ of\\ focal\\ fatty\\ sparing\\ is\\ concerning\\ and\\ could\\ misinterpreted\\ as\\ liver\\ tumor\\,\\ primary\\ of\\ metastasis\\.\\ \\ in\\ this\\ case\\,\\ the\\ focal\\ sparing\\ is\\ in\\ a\\ triangular\\ shape\\ near\\ the\\ portal\\ vein\\ which\\ is\\ consistent\\ with\\ fat\\ sparing\\ and\\ not\\ a\\ mass\\.\\ \\ \ \(0\)\
\-\ accessory\\ lobes\\ of\\ liver\\ are\\ normal\\ variant\\ and\\ if\\ asymptomatic\\ require\\ no\\ intervention\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sparing\\:\\ 0\\.37767274773171056\ \(0\)\
\-\ liver\\:\\ 0\\.34132394082431006\ \(0\)\
\-\ fatty\\:\\ 0\\.29923297024440404\ \(0\)\
\-\ infiltration\\:\\ 0\\.22181209470364738\ \(0\)\
\-\ focal\\:\\ 0\\.18833602958393864\ \(0\)\
\-\ of\\:\\ 0\\.1320365109047121\ \(0\)\
\-\ tests\\:\\ 0\\.12913547542871087\ \(0\)\
\-\ the\\:\\ 0\\.11667744285691603\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.11209043339751262\ \(0\)\
\-\ and\\:\\ 0\\.11153539319494898\ \(0\)\
\-\ is\\:\\ 0\\.11086330120220277\ \(0\)\
\-\ function\\:\\ 0\\.10922238577992645\ \(0\)\
\-\ this\\:\\ 0\\.10819214570813764\ \(0\)\
\-\ ct\\:\\ 0\\.10274640022341273\ \(0\)\
\-\ could\\:\\ 0\\.09815318196422061\ \(0\)\
\-\ accessory\\:\\ 0\\.09623288400072791\ \(0\)\
\-\ diagnosis\\:\\ 0\\.09326975238001876\ \(0\)\
\-\ spleen\\:\\ 0\\.08757319739971559\ \(0\)\
\-\ contrast\\:\\ 0\\.08741992277122307\ \(0\)\
\-\ portal\\:\\ 0\\.08609031695247392\ \(0\)\
\-\ diffuse\\:\\ 0\\.08462453565381443\ \(0\)\
\-\ renal\\:\\ 0\\.08403140119352849\ \(0\)\
\-\ diabetes\\:\\ 0\\.0821719652854925\ \(0\)\
\-\ discovered\\:\\ 0\\.08201504392115799\ \(0\)\
\-\ if\\:\\ 0\\.07840391329644628\ \(0\)\
\-\ that\\:\\ 0\\.07807895095894796\ \(0\)\
\-\ lobe\\:\\ 0\\.077981478847654\ \(0\)\
\-\ near\\:\\ 0\\.07325670251661377\ \(0\)\
\-\ guacher\\:\\ 0\\.07193319749311101\ \(0\)\
\-\ nodular\\:\\ 0\\.07163998420529895\ \(0\)\
\-\ were\\:\\ 0\\.06955804348326756\ \(0\)\
\-\ carbohydrate\\:\\ 0\\.06873601044007373\ \(0\)\
\-\ for\\:\\ 0\\.06816582910274481\ \(0\)\
\-\ to\\:\\ 0\\.06746983128459792\ \(0\)\
\-\ in\\:\\ 0\\.06713774491474996\ \(0\)\
\-\ appears\\:\\ 0\\.0658781634885174\ \(0\)\
\-\ aggressively\\:\\ 0\\.06470803111952356\ \(0\)\
\-\ misinterpreted\\:\\ 0\\.06470803111952356\ \(0\)\
\-\ vein\\:\\ 0\\.06448258631841045\ \(0\)\
\-\ with\\:\\ 0\\.06165385458797371\ \(0\)\
\-\ left\\:\\ 0\\.06137496481808636\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.06124337277170588\ \(0\)\
\-\ dating\\:\\ 0\\.06100194275765114\ \(0\)\
\-\ compare\\:\\ 0\\.06007319601930648\ \(0\)\
\-\ toxins\\:\\ 0\\.06007319601930648\ \(0\)\
\-\ glycogen\\:\\ 0\\.06007319601930648\ \(0\)\
\-\ instance\\:\\ 0\\.06007319601930648\ \(0\)\
\-\ malnutrition\\:\\ 0\\.06007319601930648\ \(0\)\
\-\ showed\\:\\ 0\\.05992004178263319\ \(0\)\
\-\ long\\:\\ 0\\.05965306256747873\ \(0\)\
\-\ record\\:\\ 0\\.059242403751793606\ \(0\)\
\-\ manager\\:\\ 0\\.059242403751793606\ \(0\)\
\-\ further\\:\\ 0\\.05859277101436967\ \(0\)\
\-\ infiltrated\\:\\ 0\\.058490860729226664\ \(0\)\
\-\ pursue\\:\\ 0\\.058490860729226664\ \(0\)\
\-\ acetaminophen\\:\\ 0\\.058490860729226664\ \(0\)\
\-\ offending\\:\\ 0\\.058490860729226664\ \(0\)\
\-\ area\\:\\ 0\\.05827770126097464\ \(0\)\
\-\ disease\\:\\ 0\\.05664332163610224\ \(0\)\
\-\ storage\\:\\ 0\\.05604521669875631\ \(0\)\
\-\ fat\\:\\ 0\\.05596097030393341\ \(0\)\
\-\ alcoholism\\:\\ 0\\.055536315389921195\ \(0\)\
\-\ primary\\:\\ 0\\.055315991432609915\ \(0\)\
\-\ appearance\\:\\ 0\\.05423368783751007\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.05377677638406367\ \(0\)\
\-\ she\\:\\ 0\\.05355133158295056\ \(0\)\
\-\ presumptive\\:\\ 0\\.053392054547144324\ \(0\)\
\-\ continuing\\:\\ 0\\.052674720834193764\ \(0\)\
\-\ calculi\\:\\ 0\\.052674720834193764\ \(0\)\
\-\ cyst\\:\\ 0\\.05189488484467901\ \(0\)\
\-\ etoh\\:\\ 0\\.05170797289700419\ \(0\)\
\-\ approx\\:\\ 0\\.051410381598539244\ \(0\)\
\-\ rise\\:\\ 0\\.05112361423245168\ \(0\)\
\-\ amyloid\\:\\ 0\\.050846910981959766\ \(0\)\
\-\ kub\\:\\ 0\\.050846910981959766\ \(0\)\
\-\ agent\\:\\ 0\\.05032103392168376\ \(0\)\
\-\ cmp\\:\\ 0\\.05007068802219125\ \(0\)\
\-\ mellitus\\:\\ 0\\.05007068802219125\ \(0\)\
\-\ obesity\\:\\ 0\\.04982804630845942\ \(0\)\
\-\ unavailable\\:\\ 0\\.04982804630845942\ \(0\)\
\-\ iron\\:\\ 0\\.04959264872339398\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.04959264872339398\ \(0\)\
\-\ aid\\:\\ 0\\.04959264872339398\ \(0\)\
\-\ abdominal\\:\\ 0\\.04920177387803369\ \(0\)\
\-\ furthermore\\:\\ 0\\.04892589397474652\ \(0\)\
\-\ consistent\\:\\ 0\\.04877863840522171\ \(0\)\
\-\ selected\\:\\ 0\\.048311149016333724\ \(0\)\
\-\ amylase\\:\\ 0\\.047740883712992774\ \(0\)\
\-\ resolve\\:\\ 0\\.047559605993766775\ \(0\)\
\-\ lipase\\:\\ 0\\.047382402277989066\ \(0\)\
\-\ imaging\\:\\ 0\\.047277277699731515\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.04720909346646382\ \(0\)\
\-\ tumor\\:\\ 0\\.047054551487186395\ \(0\)\
\-\ requested\\:\\ 0\\.047039512016624034\ \(0\)\
\-\ triangular\\:\\ 0\\.04639546167035668\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.04624234552927425\ \(0\)\
\-\ drugs\\:\\ 0\\.04498362455783944\ \(0\)\
\-\ congestion\\:\\ 0\\.04448280652341672\ \(0\)\
\-\ no\\:\\ 0\\.04388118760929112\ \(0\)\
\-\ damage\\:\\ 0\\.04378659869985779\ \(0\)\
\-\ steroid\\:\\ 0\\.043354422957438896\ \(0\)\
\-\ concerning\\:\\ 0\\.04314690483629726\ \(0\)\
\-\ 51\\:\\ 0\\.04294470828343506\ \(0\)\
\-\ shape\\:\\ 0\\.04265081463263401\ \(0\)\
\-\ stones\\:\\ 0\\.042460799811684435\ \(0\)\
\-\ determine\\:\\ 0\\.04182964437180473\ \(0\)\
\-\ diffusely\\:\\ 0\\.04182964437180473\ \(0\)\
\-\ thickness\\:\\ 0\\.04174346609873388\ \(0\)\
\-\ need\\:\\ 0\\.04140787360142401\ \(0\)\
\-\ delay\\:\\ 0\\.04124528570725222\ \(0\)\
\-\ which\\:\\ 0\\.04090592617730413\ \(0\)\
\-\ pancreatic\\:\\ 0\\.0407767181615443\ \(0\)\
\-\ testing\\:\\ 0\\.04040645138549939\ \(0\)\
\-\ lead\\:\\ 0\\.04005279419873352\ \(0\)\
\-\ variant\\:\\ 0\\.03991565624649988\ \(0\)\
\-\ dense\\:\\ 0\\.03964833459556648\ \(0\)\
\-\ require\\:\\ 0\\.03866139398793409\ \(0\)\
\-\ phase\\:\\ 0\\.03848934570450661\ \(0\)\
\-\ incidentally\\:\\ 0\\.03832097133212785\ \(0\)\
\-\ removed\\:\\ 0\\.03821068654838672\ \(0\)\
\-\ so\\:\\ 0\\.03783640181887969\ \(0\)\
\-\ intervention\\:\\ 0\\.03778435388404087\ \(0\)\
\-\ off\\:\\ 0\\.037579531108507015\ \(0\)\
\-\ lobes\\:\\ 0\\.0375291460584882\ \(0\)\
\-\ arterial\\:\\ 0\\.03704224860466973\ \(0\)\
\-\ additionally\\:\\ 0\\.03704224860466973\ \(0\)\
\-\ review\\:\\ 0\\.03704224860466973\ \(0\)\
\-\ pending\\:\\ 0\\.03699517244395449\ \(0\)\
\-\ test\\:\\ 0\\.03658367559489532\ \(0\)\
\-\ metastases\\:\\ 0\\.03636401700407479\ \(0\)\
\-\ etiology\\:\\ 0\\.0362351002334291\ \(0\)\
\-\ as\\:\\ 0\\.03614031830437468\ \(0\)\
\-\ taken\\:\\ 0\\.03594224623369406\ \(0\)\
\-\ hepatic\\:\\ 0\\.035819992102649474\ \(0\)\
\-\ films\\:\\ 0\\.03562035527501631\ \(0\)\
\-\ stable\\:\\ 0\\.035581027345616946\ \(0\)\
\-\ many\\:\\ 0\\.03546420693489679\ \(0\)\
\-\ results\\:\\ 0\\.03505008997167536\ \(0\)\
\-\ evaluate\\:\\ 0\\.034977078028754355\ \(0\)\
\-\ history\\:\\ 0\\.034370111957254576\ \(0\)\
\-\ are\\:\\ 0\\.03413591149653495\ \(0\)\
\-\ specific\\:\\ 0\\.03408475275700477\ \(0\)\
\-\ cysts\\:\\ 0\\.03408475275700477\ \(0\)\
\-\ change\\:\\ 0\\.03408475275700477\ \(0\)\
\-\ previous\\:\\ 0\\.033988000211866765\ \(0\)\
\-\ causes\\:\\ 0\\.033988000211866765\ \(0\)\
\-\ metastasis\\:\\ 0\\.03296719312340432\ \(0\)\
\-\ ago\\:\\ 0\\.03291107022812685\ \(0\)\
\-\ laboratory\\:\\ 0\\.03266334618518345\ \(0\)\
\-\ reported\\:\\ 0\\.03239692782006337\ \(0\)\
\-\ care\\:\\ 0\\.03213921751371699\ \(0\)\
\-\ obtained\\:\\ 0\\.03181631244231212\ \(0\)\
\-\ biopsy\\:\\ 0\\.031529545076224554\ \(0\)\
\-\ because\\:\\ 0\\.03143622761434662\ \(0\)\
\-\ being\\:\\ 0\\.03134400160980295\ \(0\)\
\-\ or\\:\\ 0\\.031295649776781356\ \(0\)\
\-\ labs\\:\\ 0\\.031162723890576945\ \(0\)\
\-\ given\\:\\ 0\\.030941834558912206\ \(0\)\
\-\ less\\:\\ 0\\.0306007983378799\ \(0\)\
\-\ areas\\:\\ 0\\.030538464151616613\ \(0\)\
\-\ followed\\:\\ 0\\.030374609247962096\ \(0\)\
\-\ cases\\:\\ 0\\.030253914542117642\ \(0\)\
\-\ unremarkable\\:\\ 0\\.030154727907286367\ \(0\)\
\-\ back\\:\\ 0\\.029998579567166853\ \(0\)\
\-\ density\\:\\ 0\\.029826531283739365\ \(0\)\
\-\ vascular\\:\\ 0\\.029695263961010382\ \(0\)\
\-\ patient\\:\\ 0\\.02925962863843659\ \(0\)\
\-\ known\\:\\ 0\\.029121539463273633\ \(0\)\
\-\ will\\:\\ 0\\.028950486475965962\ \(0\)\
\-\ medical\\:\\ 0\\.02858674245464961\ \(0\)\
\-\ her\\:\\ 0\\.028101102930204885\ \(0\)\
\-\ month\\:\\ 0\\.027362000457416102\ \(0\)\
\-\ carcinoma\\:\\ 0\\.026905147083419807\ \(0\)\
\-\ head\\:\\ 0\\.02682720344879208\ \(0\)\
\-\ time\\:\\ 0\\.0266609231014979\ \(0\)\
\-\ however\\:\\ 0\\.02662304360431908\ \(0\)\
\-\ performed\\:\\ 0\\.026610457434849154\ \(0\)\
\-\ been\\:\\ 0\\.026205997831682117\ \(0\)\
\-\ months\\:\\ 0\\.026182139315753108\ \(0\)\
\-\ significant\\:\\ 0\\.025970600246616675\ \(0\)\
\-\ therapy\\:\\ 0\\.025844065702819496\ \(0\)\
\-\ high\\:\\ 0\\.025563821798116424\ \(0\)\
\-\ evidence\\:\\ 0\\.025530852132667762\ \(0\)\
\-\ than\\:\\ 0\\.025498019745890495\ \(0\)\
\-\ physical\\:\\ 0\\.024389319202610855\ \(0\)\
\-\ increased\\:\\ 0\\.024323175454085785\ \(0\)\
\-\ woman\\:\\ 0\\.023425856551281786\ \(0\)\
\-\ most\\:\\ 0\\.023409079452402132\ \(0\)\
\-\ exam\\:\\ 0\\.022643075788122396\ \(0\)\
\-\ case\\:\\ 0\\.022597583930219097\ \(0\)\
\-\ large\\:\\ 0\\.02253733352439096\ \(0\)\
\-\ had\\:\\ 0\\.022410809838200176\ \(0\)\
\-\ findings\\:\\ 0\\.022199553072077802\ \(0\)\
\-\ multiple\\:\\ 0\\.02200081479535424\ \(0\)\
\-\ treatment\\:\\ 0\\.021426475488564994\ \(0\)\
\-\ images\\:\\ 0\\.02080635606658021\ \(0\)\
\-\ has\\:\\ 0\\.020545663447982403\ \(0\)\
\-\ normal\\:\\ 0\\.018365130771724948\ \(0\)\
\-\ be\\:\\ 0\\.01824668553800394\ \(0\)\
\-\ there\\:\\ 0\\.017897498275941177\ \(0\)\
\-\ from\\:\\ 0\\.017864244737996443\ \(0\)\
\-\ not\\:\\ 0\\.017757129156147022\ \(0\)\
\-\ mass\\:\\ 0\\.017181251282052255\ \(0\)\
\-\ at\\:\\ 0\\.016989606438668196\ \(0\)\
\-\ was\\:\\ 0\\.015676059293527916\ \(0\)\
\-\ year\\:\\ 0\\.013862024673028578\ \(0\)\
\-\ old\\:\\ 0\\.013312342145029321\ \(0\)\
